Cargando…
AdipoRon Alleviates Free Fatty Acid-Induced Myocardial Cell Injury Via Suppressing Nlrp3 Inflammasome Activation
BACKGROUND: Hypoadiponectinemia is a high risk factor for type 2 diabetes and cardiovascular disease. Although adiponectin is a protective molecule in cardiovascular diseases, it is hampered due to short plasma half-life and high cost of production. This study aimed to investigate whether AdipoRon,...
Autores principales: | Zhang, You-Zhi, Zhang, Yu-Lin, Huang, Qi, Huang, Cong, Jiang, Zhi-Long, Cai, Fei, Shen, Jian-Fen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817839/ https://www.ncbi.nlm.nih.gov/pubmed/31749627 http://dx.doi.org/10.2147/DMSO.S221841 |
Ejemplares similares
-
AdipoRon may be benefit for atherosclerosis prevention
por: Esfahani, Maryam, et al.
Publicado: (2017) -
AdipoRon, a new therapeutic prospect for Duchenne muscular dystrophy
por: Abou‐Samra, Michel, et al.
Publicado: (2020) -
AdipoRon Engages Microglia to Antinociception through the AdipoR1/AMPK Pathway in SNI Mice
por: Fang, Qian, et al.
Publicado: (2023) -
AdipoRon Promotes the Osseointegration of Dental Implants in Mice With Type 2 Diabetes Mellitus
por: Huang, BoRui, et al.
Publicado: (2021) -
AdipoRon and Other Adiponectin Receptor Agonists as Potential Candidates in Cancer Treatments
por: Nigro, Ersilia, et al.
Publicado: (2021)